Please see below information about transactions made under the share buy-back
programme for Nordhealth AS ("Nordhealth") (Ticker: NORDH NO).

Date on which the share buy-back programme was announced: 5 June 2023.

The duration of the buy-back programme: 5 June 2023 until no later than 31
December 2023 or the maximum share size or consideration has been reached.

Size of the buy-back programme: Up to 400,000 shares, for a maximum
consideration of NOK 4,000,000.

From 5 June 2023 until 13 June 2023, Nordhealth has purchased a total of 20,878
own shares at an average price of NOK 23.2015 per share.

Aggregated overview of transactions per day:

Date                             Aggregate daily       Weighted        Total
                                    volume (# of  average price  transaction
                                         shares)          (NOK)  value (NOK)
05.06.2023 00:00:00                        1,721        24.4023    41,996.36
06.06.2023 00:00:00                          760        23.9720    18,218.72
07.06.2023 00:00:00                          605        23.8354    14,420.42
08.06.2023 00:00:00                            0           n.a.         n.a.
09.06.2023 00:00:00                            0           n.a.         n.a.
12.06.2023 00:00:00                       17,791        23.0309   409,742.74
13.06.2023 00:00:00                            1        23.6000        23.60

Previously disclosed buy-backs                 0           n.a.         0.00
under the programme (aggregate)
Total purchased under the                 20,878        23.2015   484,401.84
programme

This information is published in accordance with the requirements in article 5
of the EU Market Abuse Regulation and subject to the disclosure requirements
pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back
programme that have been carried out during the above-mentioned time period is
attached to this report.

For further information, please contact:

Mari Orttenvuori, CFO

mari.orttenvuori@nordhealth.com

+358 46 8765 233

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 50,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with more than 380
employees working either remotely or from offices (collaboration hubs). Visit
the company's website at nordhealth.com (http://www.nordhealth.com).